Profund Advisors LLC Pacira Bio Sciences, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 17,711 shares of PCRX stock, worth $456,058. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,711

Previous 10,551 67.86%

Holding current value

$456,058

Previous $301,000 11.63%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$11.7 - $28.46 $83,772 - $203,773	7,160 Added 67.86%	17,711 $266,000
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $55,845 - $69,006	2,190 Added 26.19%	10,551 $301,000
Q1 2024 May 08, 2024	SELL	$27.7 - $35.48 $73,266 - $93,844	-2,645 Reduced 24.03%	8,361 $244,000
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $32,952 - $42,956	-1,252 Reduced 10.21%	11,006 $371,000
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $74,092 - $96,817	2,415 Added 24.54%	12,258 $376,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $47.5 $18,926 - $24,890	-524 Reduced 5.05%	9,843 $394,000
Q1 2023 May 11, 2023	BUY	$35.53 - $43.38 $155,017 - $189,266	4,363 Added 72.67%	10,367 $423,000
Q4 2022 Feb 02, 2023	SELL	$38.19 - $57.45 $11,304 - $17,005	-296 Reduced 4.7%	6,004 $231,000
Q3 2022 Nov 04, 2022	SELL	$51.24 - $58.89 $17,780 - $20,434	-347 Reduced 5.22%	6,300 $335,000
Q2 2022 Aug 01, 2022	SELL	$51.49 - $81.64 $36,918 - $58,535	-717 Reduced 9.74%	6,647 $388,000
Q1 2022 May 10, 2022	BUY	$60.03 - $76.49 $8,404 - $10,708	140 Added 1.94%	7,364 $562,000
Q4 2021 Feb 08, 2022	BUY	$47.97 - $62.21 $6,140 - $7,962	128 Added 1.8%	7,224 $435,000
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $50,378 - $56,518	-922 Reduced 11.5%	7,096 $397,000
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $32,430 - $38,354	548 Added 7.34%	8,018 $487,000
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $36,534 - $48,553	-616 Reduced 7.62%	7,470 $524,000
Q4 2020 Feb 09, 2021	BUY	$50.47 - $66.26 $90,795 - $119,201	1,799 Added 28.61%	8,086 $484,000
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $20,320 - $24,633	-391 Reduced 5.86%	6,287 $378,000
Q2 2020 Aug 03, 2020	BUY	$30.8 - $52.47 $205,682 - $350,394	6,678 New	6,678 $350,000
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $206,723 - $369,045	-7,279 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$36.31 - $46.83 $6,681 - $8,616	-184 Reduced 2.47%	7,279 $330,000
Q3 2019 Nov 12, 2019	BUY	$35.66 - $44.99 $266,130 - $335,760	7,463 New	7,463 $284,000
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $225,639 - $260,905	-6,187 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $114,552 - $144,639	-2,773 Reduced 30.95%	6,187 $266,000
Q3 2018 Nov 13, 2018	BUY	$32.85 - $52.0 $294,336 - $465,920	8,960 New	8,960 $440,000

Others Institutions Holding PCRX

# of Institutions

253

Shares Held

48.5M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.18B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Pacira Bio Sciences, Inc. Transaction History